I-CAN IPSEN COMPREHENSIVE CARE APPROACHFOR PATIENTS SUFFERING FROM SPASTIC PARESIS
DEAD

Serial Number

86855235

Owner

IPSEN BIOPHARM LIMITED

Attorney

G MATHEW LOMBARD

Filing Date

Dec 21, 2015

Add to watchlist:

No watchlists yet
View on USPTO

I-CAN IPSEN COMPREHENSIVE CARE APPROACHFOR PATIENTS SUFFERING FROM SPASTIC PARESIS Trademark

Serial Number: 86855235

I-CAN IPSEN COMPREHENSIVE CARE APPROACHFOR PATIENTS SUFFERING FROM SPASTIC PARESIS is a trademark filed by IPSEN BIOPHARM LIMITED on December 21, 2015. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

IPSEN BIOPHARM LIMITED (68 trademarks)

ASH ROAD
WREXHAM LL13 9UF , GB

Entity Type: 03

Trademark Details

Filing Date

December 21, 2015

Registration Date

Not Registered

Goods & Services

Education, namely, providing congresses and workshops in the fields of healthcare, disease diagnosis, disease treatment and medical procedures; providing of training services in the field of healthcare, disease diagnosis, disease treatment, medical procedures coaching services in the fields of healthcare, disease diagnosis, disease treatment and medical procedures; physical education; practical training in the fields of healthcare, disease diagnosis, disease treatment and medical procedures; arranging and conducting of colloquiums, conferences, workshops, seminars, symposiums in the fields of healthcare, disease diagnosis, disease treatment and medical procedures; publication of texts, other than publicity texts in the fields of healthcare, disease diagnosis, disease treatment and medical procedures

Medical services; health counseling; medical advice for the treatment of individuals with disabilities; physiotherapy

Scientific research for medical purposes

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Oct 1, 2019 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Oct 1, 2019 ABN2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Feb 28, 2019 GNS2
INQUIRY TO SUSPENSION E-MAILED
Feb 28, 2019 GNSI
SUSPENSION INQUIRY WRITTEN
Feb 28, 2019 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Feb 21, 2019 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Aug 10, 2018 GNS3
LETTER OF SUSPENSION E-MAILED
Aug 10, 2018 GNSL
SUSPENSION LETTER WRITTEN
Aug 10, 2018 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 25, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 25, 2018 CRFA
ASSIGNED TO LIE
Jul 25, 2018 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jul 23, 2018 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jan 24, 2018 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jan 24, 2018 GNSI
SUSPENSION INQUIRY WRITTEN
Jan 24, 2018 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jan 23, 2018 RCCK
ASSIGNED TO LIE
Jan 23, 2018 ALIE
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 10, 2017 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 10, 2017 GNSL
SUSPENSION LETTER WRITTEN
Jul 10, 2017 CNSL
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jun 5, 2017 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Dec 12, 2016 GNS2
INQUIRY TO SUSPENSION E-MAILED
Dec 12, 2016 GNSI
SUSPENSION INQUIRY WRITTEN
Dec 12, 2016 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jun 10, 2016 GNS3
LETTER OF SUSPENSION E-MAILED
Jun 10, 2016 GNSL
SUSPENSION LETTER WRITTEN
Jun 10, 2016 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 9, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 9, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 9, 2016 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 14, 2016 GNRN
NON-FINAL ACTION E-MAILED
Apr 14, 2016 GNRT
NON-FINAL ACTION WRITTEN
Apr 14, 2016 CNRT
ASSIGNED TO EXAMINER
Apr 8, 2016 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Dec 31, 2015 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 30, 2015 NWOS
NEW APPLICATION ENTERED
Dec 28, 2015 NWAP